LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Impact of Chronic RAAS Use in Elderly COVID-19 Patients: A Retrospective Analysis.

    Oliveira, João / Gameiro, Joana / Bernardo, João / Marques, Filipe / Costa, Cláudia / Branco, Carolina / Duarte, Inês / Fonseca, José / Carreiro, Carolina / Braz, Sandra / Lopes, José António

    Journal of clinical medicine

    2021  Volume 10, Issue 14

    Abstract: ... that these medications might increase the risk of mortality by COVID-19. This is a retrospective cohort of 346 patients ... 113, 32.7%). Ninety-eight patients (28.3%) had chronic kidney disease and almost half of the patients ... old. Most patients had arterial hypertension (n = 279, 80.6%), almost half (n = 161, 46.5%) had ...

    Abstract Corona Virus Disease-19 (COVID-19) recently emerged as a global pandemic. Advanced age is the most important risk factor for increased virus susceptibility and worse outcomes. Many older adults are currently treated with renin-angiotensin-aldosterone system (RAAS) inhibitors and there is concern that these medications might increase the risk of mortality by COVID-19. This is a retrospective cohort of 346 patients older than 65 years with COVID-19, at the Department of Medicine of the Centro Hospitalar Universitário Lisboa Norte, in Portugal, hospitalized between March 2020 and August 2020. Mean age was 80.9 ± 8.7 years old. Most patients had arterial hypertension (n = 279, 80.6%), almost half (n = 161, 46.5%) had cardiovascular disease and approximately one-third of patients had heart failure (n = 127, 36.7%) or diabetes Mellitus (n = 113, 32.7%). Ninety-eight patients (28.3%) had chronic kidney disease and almost half of the patients (49.4%) were chronically under renin-angiotensin-aldosterone system (RAAS) inhibitors. Twenty percent of patients died during hospitalization. In a multivariate analysis, older age (OR 1.11, 95% CI 1.04, 1.18,
    Language English
    Publishing date 2021-07-16
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm10143147
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Impact of Chronic RAAS Use in Elderly COVID-19 Patients

    João Oliveira / Joana Gameiro / João Bernardo / Filipe Marques / Cláudia Costa / Carolina Branco / Inês Duarte / José Fonseca / Carolina Carreiro / Sandra Braz / José António Lopes

    Journal of Clinical Medicine, Vol 10, Iss 3147, p

    A Retrospective Analysis

    2021  Volume 3147

    Abstract: ... that these medications might increase the risk of mortality by COVID-19. This is a retrospective cohort of 346 patients ... 113, 32.7%). Ninety-eight patients (28.3%) had chronic kidney disease and almost half of the patients ... old. Most patients had arterial hypertension (n = 279, 80.6%), almost half (n = 161, 46.5%) had ...

    Abstract Corona Virus Disease-19 (COVID-19) recently emerged as a global pandemic. Advanced age is the most important risk factor for increased virus susceptibility and worse outcomes. Many older adults are currently treated with renin–angiotensin–aldosterone system (RAAS) inhibitors and there is concern that these medications might increase the risk of mortality by COVID-19. This is a retrospective cohort of 346 patients older than 65 years with COVID-19, at the Department of Medicine of the Centro Hospitalar Universitário Lisboa Norte, in Portugal, hospitalized between March 2020 and August 2020. Mean age was 80.9 ± 8.7 years old. Most patients had arterial hypertension (n = 279, 80.6%), almost half (n = 161, 46.5%) had cardiovascular disease and approximately one-third of patients had heart failure (n = 127, 36.7%) or diabetes Mellitus (n = 113, 32.7%). Ninety-eight patients (28.3%) had chronic kidney disease and almost half of the patients (49.4%) were chronically under renin–angiotensin–aldosterone system (RAAS) inhibitors. Twenty percent of patients died during hospitalization. In a multivariate analysis, older age (OR 1.11, 95% CI 1.04, 1.18, p = 0.002), absence of baseline medication with RAAS inhibitors (OR 0.27, 95% CI 0.10, 0.75, p = 0.011), higher serum ferritin (OR 1.00, 95% CI 1.00, 1.00, p = 0.003) and higher lactate levels (OR 1.08, 95% CI 1.02, 1.14, p = 0.006) were independent predictors of mortality. Older age, higher serum ferritin and lactate levels at admission were found to be independent predictors of mortality and might act as early predictors of worsening disease in clinical practice. Chronic treatment with RAAS inhibitors appeared to be protective, supporting guidelines in not discontinuing such drugs.
    Keywords elderly ; COVID-19 ; renin–angiotensin–aldosterone system ; mortality ; Medicine ; R
    Subject code 610 ; 616
    Language English
    Publishing date 2021-07-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top